Latest Natalizumab Stories
ProgressiveMultifocalLeukoencephalopathy.org aims to assist individuals in learning about PML. (PRWEB) November 28, 2011 Flood Law Group, LLP, a litigation
Taking the new generation anti-inflammatory drug natalizumab for two years lowers the number of remitting multiple sclerosis patients who experience relapses and progression of disability.
Biopharma intelligence provider will also moderate live panel on funding biopharma innovation at Prix Galien USA on September 27 in NYC. Norwood, MA (PRWEB)